Pexidartinib - Latest Advances

In Vitro and In Vivo Ocular Safety Assessment of Pexidartinib.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: October 28, 2026

Assessing the effectiveness of the TURALIO (pexidartinib) risk evaluation and mitigation strategy program: patient knowledge, attitudes, and behavior survey (2020-2024).

Journal: Patient related outcome measures

Published: September 04, 2026

Efficacy and Safety of CSF1R Inhibitors for Recurrent or Unresectable Tenosynovial Giant Cell Tumor: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials.

Journal: Asia-Pacific journal of clinical oncology

Published: September 04, 2026

7-azaindole as privileged scaffold: Advances in drug design and structural modification.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Published: June 17, 2026

Targeting the MAPK/ERK signaling pathway: Mechanistic analysis of pexidartinib in overcoming adriamycin resistance in breast cancer.

Journal: Experimental cell research

Published: May 19, 2026

WTAP Transcriptional Suppression by KLF9 Drives Osteoclastogenesis via M6A-Mediated Regulation of CSF1R Signaling in Estrogen-Deficient Osteoporosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 18, 2026

Corrigendum to "Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver" [J. Pharm. Biomed. Anal. 265 (2025) 117034].

Journal: Journal of pharmaceutical and biomedical analysis

Published: May 15, 2026

Pexidartinib in patients with tenosynovial giant cell tumor: a plain language summary of the final results from ENLIVEN.

Journal: Future oncology (London, England)

Published: May 14, 2026

PCO26-273: Development and Evaluation of a Crosslinked β-cyclodextrin Nanocarrier for Codelivery of Doxorubicin and Pexidartinib in Colorectal Cancer Therapy.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 01, 2026

PCO26-273: Development and Evaluation of a Crosslinked β-cyclodextrin Nanocarrier for Codelivery of Doxorubicin and Pexidartinib in Colorectal Cancer Therapy.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

PLX3397 Reshapes Hepatic Lipid Metabolism Independent of Microglial Depletion.

Journal: Neuroscience bulletin

Published: March 21, 2026

Integrative transcriptomics, machine learning, and molecular docking derive a DAM-like macrophage signature for risk stratification and therapeutic nomination in glioblastoma.

Journal: Computational biology and chemistry

Published: February 23, 2026